mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein

Autor: Mancini, Manuela a, ⁎, Corradi, Valentina b, Petta, Sara a, Martinelli, Giovanni a, Barbieri, Enza c, Santucci, Maria Alessandra a
Zdroj: In Leukemia Research 2010 34(5):641-648
Databáze: ScienceDirect